Pilot Study of NanoKnife System for Ablation of Prostate Cancer
This study, initiated by AngioDynamics, Inc., will evaluate the use of the NanoKnife System as a focal therapy option for prostate cancer. It will assess the short-term safety of the device when used to ablate localized prostate cancer in low and intermediate risk subjects.